JNJ · NYQ S&P 500

Johnson & Johnson

Healthcare · Drug Manufacturers - General

$280.78 −$1.33 (−0.47%) today

Closing price on Nov 10, 2026 · Source: Yahoo Finance

Consensus of 23 analysts

Buy

Median price target $280.50 −0.1%

Open: $282.00
Day range: 279.20 – $283.25
52-week range: 189.05 – $283.25
Volume: 7,350,117
Market cap: $675,925M
P/E (TTM): 42.6x
EPS (TTM): $6.59
EPS est. 2026: $11.12
P/E est. 2026: 25.3x
Dividend yield: 1.9%
Beta: 0.20
Payout: 80%

Johnson & Johnson financials

Q3 2026 results, quarter ended Sep 30, 2026

Metric	Q3 2026	1-year change
Total revenue	$25,399M	+5.9%
Net income	$210M	−95.9%
Earnings per share	$0.09	−95.9%
Net margin	0.8%	−20.6 pp
Free cash flow	$5,363M	−32.9%
Debt / equity	0.55	−5.2%

Revenue and net income ($M)

Total revenueNet income

Quarter	Total revenue	Net income
Q3 2025	$23,993M	$5,152M
Q4 2025	$24,564M	$5,116M
Q1 2026	$24,062M	$5,235M
Q2 2026	$25,310M	$5,534M
Q3 2026	$25,399M	$210M

Johnson & Johnson earnings per share (EPS)

Consensus estimates

Period	EPS est.	1-year change
Current quarterQ4 2026 · Analysts: 17	$2.9152.86 – 2.97	+18.5%$2.460
Next quarterQ1 2027 · Analysts: 7	$2.6742.57 – 2.87	−1.0%$2.700
Current year2026 · Analysts: 21	$11.12011.05 – 11.28	+3.1%$10.790
Next yearFY 2027 · Analysts: 22	$11.62210.75 – 13.34	+4.5%$11.120

Forward P/E: 25.3x (2026) and 24.2x (FY 2027) at the current price.

Actual and estimated EPS ($)

Actual EPSEstimated EPS

Quarter	Actual EPS	Estimated EPS
Q3 2025	$2.120	—
Q4 2025	$2.460	$2.463
Q1 2026	$2.700	$2.677
Q2 2026	$2.900	$2.855
Q3 2026	$2.590	$2.522
Q4 2026	—	$2.915
Q1 2027	—	$2.674

Year	Actual EPS	Estimated EPS
2022	$6.730	—
2023	$13.720	—
2024	$5.790	—
2025	$11.030	—
2026	—	$11.120
FY 2027	—	$11.622

EPS trend

Quarter	EPS	YoY change
Q1 2027Estimated	$2.674	−1.0%
Q4 2026Estimated	$2.915	+18.5%
Q3 2026	$2.590est. $2.522 · surprise +2.7%	+22.2%
Q2 2026	$2.900est. $2.855 · surprise +1.6%	n/a
Q1 2026	$2.700est. $2.677 · surprise +0.9%	n/a
Q4 2025	$2.460est. $2.463 · surprise −0.1%	n/a
Q3 2025	$2.120	n/a

Year	EPS	Annual change
FY 2027Estimated	$11.622	+4.5%
2026Estimated	$11.120	+0.8%
2025	$11.030	+90.5%
2024	$5.790	−57.8%
2023	$13.720	+103.9%
2022	$6.730	n/a

Normalised EPS according to the analyst consensus collected by Yahoo Finance; it may differ from the reported EPS in the results table.

Johnson & Johnson dividend

Yield and payments

Dividend yield (TTM)	1.9%
Forward yield (next 12m)	1.9%
Dividend per share (TTM)	$5.28
Forward dividend (next 12m)	$5.36
Payout (TTM)	80%
Last dividend	$1.34Aug 25, 2026
Next ex-dividend date	Nov 24, 2026

Dividend per share by year ($)

PaidEstimated

Year	Dividend per share
2019	$3.75
2020	$3.98
2021	$4.19
2022	$4.45
2023	$4.70
2024	$4.91
2025	$5.14
est. 12m	$5.36

Johnson & Johnson forecasts

23 analyst ratings

Buy70% Hold26% Sell4%

Consensus: Buy · 16 buy, 6 hold, 1 sell

1-year price forecast

Share price Price target (high, median, low)

12-month price targets
Target	Price	Upside
High	$320.00	+14.0%
Median	$280.50	−0.1%
Low	$190.00	−32.3%

Monthly close (last 12 months)
Date	Close
Nov 28, 2025	$206.92
Dec 31, 2025	$206.95
Jan 30, 2026	$227.25
Feb 27, 2026	$248.43
Mar 31, 2026	$244.44
Apr 30, 2026	$229.85
May 29, 2026	$225.33
Jun 30, 2026	$253.97
Jul 31, 2026	$256.35
Aug 31, 2026	$265.85
Sep 30, 2026	$264.74
Oct 30, 2026	$273.20
Nov 10, 2026	$280.78

Johnson & Johnson peers

Ticker	Company	Market cap ($M)	P/E	Price ($)	1-day change	52-week range
JNJ	Johnson & Johnson	675,925	42.6x	280.78	−0.47%	189.05283.25
LLY	Lilly	1,275,805	46.5x	1,432.29	+1.44%	850.511,453.00
ABBV	AbbVie	519,485	50.5x	293.89	+0.20%	190.75302.93
MRK	Merck &	364,980	149.5x	148.05	−0.48%	87.26156.92
AMGN	Amgen	251,648	27.0x	465.23	0.00%	312.39483.99
GILD	Gilead Sciences	211,937	n/a	170.87	+0.92%	116.88176.58